Abstract
New treatment strategies for platinum-resistant recurrent ovarian cancer are needed. Programmed cell death-1 (PD-1) signaling is a new target of antitumor therapy that involves immune reactivation; however, its antitumor effect on subsequent chemotherapy is unclear. Two representative cases are described here.
Cite
CITATION STYLE
APA
Yoshida, G. J. (2018). Regarding “Improved Detection of Circulating Epithelial Cells in Patients with Intraductal Papillary Mucinous Neoplasms.” The Oncologist, 23(10), e119–e119. https://doi.org/10.1634/theoncologist.2018-0148
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free